Covered recipient · General Payments record
BRUCE R BRADY
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2022
$7,152.67
- Reported across 491 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $184.37 | 11 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $69.30 | 4 |
| ABBVIE INC. | $31.11 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.35 | 1 |
| Lilly USA, LLC | $18.14 | 1 |
| Antares Pharma, Inc. | $15.95 | 1 |
| Rhythm Pharmaceuticals, Inc. | $14.81 | 1 |
| DEXCOM, INC. | $14.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.00 | 01/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 920475877 | CMS |
| Abbott Laboratories | $21.17 | 02/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 920475885 | CMS |
| Abbott Laboratories | $14.50 | 03/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 914211311 | CMS |
| Abbott Laboratories | $17.63 | 03/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 914211317 | CMS |
| ABBVIE INC. | $14.27 | 01/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890649251 | CMS |
| ABBVIE INC. | $16.84 | 03/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890649253 | CMS |
| Antares Pharma, Inc. | $15.95 | 02/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 956816361 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.35 | 02/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 887368515 | CMS |
| Dexcom, Inc. | $14.71 | 01/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 957404005 | CMS |
| Lilly USA, LLC | $18.14 | 02/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 917927383 | CMS |
| Rhythm Pharmaceuticals, Inc. | $14.81 | 01/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 954217875 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.